Back

Biological versus mechanical SAVR patient's age threshold: PARTNER II study influenced real world practice in a large French cohort.

26 August 2023 (10:15 - 11:00)
Organised by: Logo
Congress Presentation Part of: New insights around surgical valve replacement Surgery ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Yuthiline Chabry

Hospital Bichat-Claude Bernard, Paris (France)

6 More presentations in this session

Presentation thumbnail
Three-year outcomes following transcatheter versus surgical aortic valve replacement in younger, low surgical risk patients with severe aortic stenosis
Professor T. Modine (Bordeaux, FR) Professor N. van Mieghem (Rotterdam, NL)
Abstract Slides Video
Presentation thumbnail
Predictors of major adverse cardiovascular events in patients with severe aortic stenosis awaiting aortic valve replacement
Doctor I. Fialho (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Early mitral valve repair surgery versus active surveillance in patients with asymptomatic severe primary mitral regurgitation; insights from the Dutch AMR registry
Doctor S. El Mathari (Amsterdam, NL)
Abstract Slides Video
Presentation thumbnail
Elderly patients with severe aortic stenosis - does moderate mitral regurgitation require simultaneous surgical intervention?
Doctor A. Kwiecien (Zabrze, PL)
Abstract Slides Video
Presentation thumbnail
Progression of non-significant mitral and tricuspid regurgitation after surgical aortic valve replacement for aortic regurgitation
Doctor S. Kazum (Petah Tikva, IL)
Abstract Slides Video

Access the full session

Session thumbnail
New insights around surgical valve replacement

The Event

Event poster

ESC Congress 2023

26 August 2023 10:15 CET
You may be interested in
thumbnail
Congress Presentation
Bioprosthetic or mechanical valve replacement: what do the data tell us?
thumbnail
Congress Presentation
TAVI should be the first procedure if a biological valve is chosen: pro
thumbnail
Congress Session
Personalising treatment strategies for aortic valve stenosis: matching therapies to patients

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources